基本資料
種類: ETF
費用比率%: 1.11
資產淨值: 20.46
成立日期: 23/04/1987
 
分析
市值分佈:
52.66%
大市值
23.01%
中市值
11.27%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 21/02/2026 06:08) 總持有投資項目: 92  
0%
 
100%
     10大 (23.91%)
代號 名稱 佔比% 持有日期
GRALGRAIL Inc.0.8531/01/2026
ABVXAbivax SA0.8431/01/2026
ABBVABBVIE0.8331/01/2026
HUMHumana0.8231/01/2026
GPCRStructure Therapeutics0.8131/01/2026
NEONeoGenomics0.8131/01/2026
VCELVericel Corp0.8031/01/2026
BDXBecton Dickinson and Co0.8031/01/2026
NUVLNuvalent0.8031/01/2026
DYNDyne Therapeutics0.7931/01/2026
BSXBoston Scientific Corp0.7931/01/2026
JBIOJade Biosciences Inc0.7931/01/2026
AZNAstraZeneca PLC0.7331/12/2025
GERNGeron Corp0.7331/01/2026
LLYEli Lilly & Co0.7031/01/2026
DXCMDexCom0.6931/01/2026
CRLCharles River Laboratories International0.6831/01/2026
BMYBristol-Myers Squibb Co0.6831/01/2026
BCRXBioCryst Pharmaceuticals0.6831/01/2026
ARQTArcutis Biotherapeutics0.6631/01/2026
  1    2   3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.